D. E. Shaw & Co., Inc. - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 133 filers reported holding PDL BIOPHARMA INC in Q3 2020. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$4,136,000
-22.5%
1,313,099
-28.4%
0.00%
-33.3%
Q2 2020$5,335,000
-0.7%
1,833,312
-3.8%
0.01%
-25.0%
Q1 2020$5,373,000
+1.4%
1,905,053
+16.6%
0.01%
+33.3%
Q4 2019$5,301,000
+13.8%
1,633,651
-24.2%
0.01%0.0%
Q3 2019$4,657,000
-24.0%
2,156,167
+10.5%
0.01%
-25.0%
Q2 2019$6,125,000
-18.1%
1,950,448
-2.9%
0.01%
-20.0%
Q1 2019$7,476,000
+8.9%
2,009,449
-15.1%
0.01%
+11.1%
Q4 2018$6,867,000
+23.8%
2,367,954
+12.3%
0.01%
+28.6%
Q3 2018$5,547,000
+1.4%
2,109,113
-9.8%
0.01%0.0%
Q2 2018$5,469,000
-23.2%
2,337,141
-3.5%
0.01%
-30.0%
Q1 2018$7,121,000
+29.0%
2,422,223
+20.2%
0.01%
+25.0%
Q4 2017$5,522,000
-38.2%
2,015,353
-23.6%
0.01%
-42.9%
Q3 2017$8,938,000
+82.7%
2,636,405
+33.1%
0.01%
+75.0%
Q2 2017$4,893,000
+17.5%
1,980,985
+8.0%
0.01%
+14.3%
Q1 2017$4,165,000
+33.5%
1,834,514
+24.6%
0.01%
+40.0%
Q4 2016$3,121,000
+54.0%
1,472,189
+143.4%
0.01%
+25.0%
Q3 2016$2,026,000
-1.7%
604,794
-7.9%
0.00%0.0%
Q2 2016$2,062,000
-48.6%
656,598
-45.5%
0.00%
-42.9%
Q1 2016$4,010,000
+68.5%
1,204,218
+79.1%
0.01%
+75.0%
Q4 2015$2,380,000
+3300.0%
672,366
+6071.3%
0.00%
Q2 2015$70,000
-90.1%
10,895
-89.2%
0.00%
-100.0%
Q1 2015$707,000
+109.8%
100,495
+129.9%
0.00%
Q4 2014$337,000
-16.0%
43,713
-7.9%
0.00%
-100.0%
Q4 2013$401,00047,4560.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders